EGF Theramed Health (EVAHF) Stock Price, News & Analysis

Company Overview

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: $0.09 to $0.09
• 50-Day Range: $0.04 to $0.09
• 52-Week Range: $0.01 to $0.23
• Volume: N/A
• Average Volume: 1,508 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EVAHF Stock Analysis - Frequently Asked Questions

How have EVAHF shares performed this year?

EGF Theramed Health's stock was trading at $0.1028 at the beginning of 2025. Since then, EVAHF shares have decreased by 8.6% and is now trading at $0.0940.
View the best growth stocks for 2025 here.

When did EGF Theramed Health's stock split?

Shares of EGF Theramed Health reverse split before market open on Monday, July 11th 2022. The 1-20 reverse split was announced on Monday, July 11th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 11th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of EGF Theramed Health?

Shares of EVAHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EVAHF
• CIK: N/A
• Web: theramedhealthcorp.com
• Phone: (778) 331-4303
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A